Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2009

01-02-2009 | Gastrointestinal Oncology

Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes

Authors: Da-zhi Xu, MD, Qi-rong Geng, Zi-jie Long, PhD, You-qing Zhan, MD, Wei Li, Zhi-wei Zhou, MD, Ying-bo Chen, Xiao-wei Sun, Gong Chen, MD, Quentin Liu, MD, PhD

Published in: Annals of Surgical Oncology | Issue 2/2009

Login to get access

Abstract

The purpose of this study was to clarify the outcome of the ratio between metastatic and examined lymph nodes (N ratio) in gastric cancer patients with ≤15 examined lymph nodes after D2 lymphadenectomy. A retrospective study was performed in 906 patients with gastric cancer who had undergone D2 resection. Patients with ≤15 examined lymph nodes (group 1, n = 729) and those with >15 lymph nodes (group 2, n = 177) were analyzed separately. N ratio categories were identified as follows: N ratio 0, 0%; N ratio 1, 1% to 9%; N ratio 2, 10% to 25%; N ratio 3, >25%. Univariate analysis found that both the tumor, node, metastasis system (N staging system) and N ratio system well classified patients with significantly different prognosis. By multivariate analysis, only the N ratio classification was retained as an independent prognostic factor in both group 1 and 2 compared with the N stage system. Furthermore, when patients were divided into four groups according to the number of lymph nodes examined (1 to 3, 4 to 7, 8 to 11, and 12 to 15), the 5-year survival rates remained similar between groups according to the same N ratio (p > .05). Positive N ratio classification is a better prognostic tool compared with N staging system after D2 resection in patients with gastric cancer. It can prevent stage migration and can be used regardless of the examined number of lymph nodes.
Literature
1.
go back to reference Sobin LH, Wittenkind CH, International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley, 1997. Sobin LH, Wittenkind CH, International Union Against Cancer (UICC). TNM classification of malignant tumors. 5th ed. New York: Wiley, 1997.
2.
go back to reference Sobin LH, Wittenkind CH, International Union Against Cancer. TNM classification of malignant tumors. 6th ed. New York: John Wiley-Liss, 2002. Sobin LH, Wittenkind CH, International Union Against Cancer. TNM classification of malignant tumors. 6th ed. New York: John Wiley-Liss, 2002.
3.
go back to reference Kranenbarg EK, Hermans J, Krieken JHJMV, et al. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001;84:64–71.CrossRef Kranenbarg EK, Hermans J, Krieken JHJMV, et al. Evaluation of the 5th edition of the TNM classification for gastric cancer: improved prognostic value. Br J Cancer. 2001;84:64–71.CrossRef
4.
go back to reference Celen O, Yildirim E, Gulben K, et al. Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system. Eur J Surg Suppl. 2003;588:33–9.PubMed Celen O, Yildirim E, Gulben K, et al. Prediction of survival in gastric carcinoma related to lymph node grading by the new American Joint Committee on Cancer/Union International Contre le Cancer System or the Japanese system. Eur J Surg Suppl. 2003;588:33–9.PubMed
5.
go back to reference Aurello P, D’Angelo F, Rossi S, et al. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg. 2007;73:359–66.PubMed Aurello P, D’Angelo F, Rossi S, et al. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg. 2007;73:359–66.PubMed
6.
go back to reference Ichikawa D, Kurioka H, Ueshima Y, et al. Prognostic value of lymph node staging in gastric cancer. Hepatogastroenterology. 2003;50:301–4.PubMed Ichikawa D, Kurioka H, Ueshima Y, et al. Prognostic value of lymph node staging in gastric cancer. Hepatogastroenterology. 2003;50:301–4.PubMed
7.
go back to reference Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–51.PubMedCrossRef Coburn NG, Swallow CJ, Kiss A, et al. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer. 2006;107:2143–51.PubMedCrossRef
8.
go back to reference Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604–8.PubMed Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312:1604–8.PubMed
9.
go back to reference Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10:1077–85.PubMedCrossRef Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10:1077–85.PubMedCrossRef
10.
go back to reference de Manzoni G, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer. 2002;87:171–4.PubMedCrossRef de Manzoni G, Verlato G, Roviello F, et al. The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer. 2002;87:171–4.PubMedCrossRef
11.
go back to reference Bunt AMG, Hermans J, Smit VTHBM, et al. Surgical/pathologic-stage migration confronts comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol. 1995;13:19–25.PubMed Bunt AMG, Hermans J, Smit VTHBM, et al. Surgical/pathologic-stage migration confronts comparisons of gastric cancer survival rate between Japan and Western countries. J Clin Oncol. 1995;13:19–25.PubMed
12.
go back to reference Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27–34.PubMedCrossRef Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27–34.PubMedCrossRef
13.
go back to reference Kunisaki C, Shimada H, Nomura M, et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res. 2005;25:1369–76.PubMed Kunisaki C, Shimada H, Nomura M, et al. Clinical impact of metastatic lymph node ratio in advanced gastric cancer. Anticancer Res. 2005;25:1369–76.PubMed
14.
go back to reference Estes NC, MacDonald JS, Touijer K, et al. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am Surg. 1998;64:680–5.PubMed Estes NC, MacDonald JS, Touijer K, et al. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report. Am Surg. 1998;64:680–5.PubMed
15.
go back to reference MacDonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.PubMedCrossRef MacDonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.PubMedCrossRef
16.
go back to reference Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35.PubMedCrossRef Kooby DA, Suriawinata A, Klimstra DS, et al. Biologic predictors of survival in node-negative gastric cancer. Ann Surg. 2003;237:828–35.PubMedCrossRef
17.
go back to reference Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol. 2005;12:981–7.PubMedCrossRef Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol. 2005;12:981–7.PubMedCrossRef
18.
go back to reference Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–32.PubMedCrossRef Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer. 2000;88:921–32.PubMedCrossRef
19.
go back to reference Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology: part I. Jpn J Surg. 1981;11:127–39.CrossRef Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology: part I. Jpn J Surg. 1981;11:127–39.CrossRef
20.
go back to reference Yu W, Choi GS, Whang I, et al. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg. 1997;84:1305–9.PubMedCrossRef Yu W, Choi GS, Whang I, et al. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg. 1997;84:1305–9.PubMedCrossRef
21.
go back to reference Sandra L, Hong J, Brent K, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149–54.CrossRef Sandra L, Hong J, Brent K, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149–54.CrossRef
22.
go back to reference Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)—report on 370 patients. Int J Radiat Oncol Biol Phys. 1998;42:929–34.PubMed Zhang ZX, Gu XZ, Yin WB, et al. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)—report on 370 patients. Int J Radiat Oncol Biol Phys. 1998;42:929–34.PubMed
23.
go back to reference Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232:362–71.PubMedCrossRef Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg. 2000;232:362–71.PubMedCrossRef
24.
go back to reference Celen O, Yildirim E, Berberoglu U, et al. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol. 2007;96:95–101.PubMedCrossRef Celen O, Yildirim E, Berberoglu U, et al. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol. 2007;96:95–101.PubMedCrossRef
25.
go back to reference Cheong JH, Hyung WJ, Shen JG, et al. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol. 2006;13:377–85.PubMedCrossRef Cheong JH, Hyung WJ, Shen JG, et al. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol. 2006;13:377–85.PubMedCrossRef
26.
go back to reference Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159–65.PubMed Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159–65.PubMed
27.
go back to reference Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol. 1998;69:15–20.PubMedCrossRef Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol. 1998;69:15–20.PubMedCrossRef
28.
go back to reference Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775–84.PubMedCrossRef Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775–84.PubMedCrossRef
29.
go back to reference Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008;97:132–5.PubMedCrossRef Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008;97:132–5.PubMedCrossRef
30.
go back to reference Therneau TM, Grambsh PM, Flemming TR. Martingale based residuals for survival models. Biometrika. 1990;77:147–60.CrossRef Therneau TM, Grambsh PM, Flemming TR. Martingale based residuals for survival models. Biometrika. 1990;77:147–60.CrossRef
31.
go back to reference Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (n ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenentomy. Ann Surg. 2007;245:543–52.PubMedCrossRef Marchet A, Mocellin S, Ambrosi A, et al. The ratio between metastatic and examined lymph nodes (n ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenentomy. Ann Surg. 2007;245:543–52.PubMedCrossRef
32.
go back to reference Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069–77.PubMedCrossRef Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22:2069–77.PubMedCrossRef
33.
go back to reference Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–30.PubMedCrossRef Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–30.PubMedCrossRef
34.
go back to reference Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24:2188–96.PubMedCrossRef Ohtsu A, Yoshida S, Saijo N. Disparities in gastric cancer chemotherapy between the East and West. J Clin Oncol. 2006;24:2188–96.PubMedCrossRef
Metadata
Title
Positive Lymph Node Ratio Is an Independent Prognostic Factor in Gastric Cancer After D2 Resection Regardless of the Examined Number of Lymph Nodes
Authors
Da-zhi Xu, MD
Qi-rong Geng
Zi-jie Long, PhD
You-qing Zhan, MD
Wei Li
Zhi-wei Zhou, MD
Ying-bo Chen
Xiao-wei Sun
Gong Chen, MD
Quentin Liu, MD, PhD
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0240-4

Other articles of this Issue 2/2009

Annals of Surgical Oncology 2/2009 Go to the issue